TradingKey - CoreWeave, Inc. (NASDAQ: CRWV) will report its Q2 FY2025 earnings on Tuesday, August 12, 2025, after the U.S. market closes. The earnings call is scheduled for 5:00 p.m. Eastern Time.
Since its IPO in March 2025 at $40 per share, CoreWeave has experienced significant volatility. The stock soared to a high of $187 in June 2025, reflecting investor enthusiasm for its AI infrastructure leadership, before sliding approximately 35% to around $121 as of August 7, 2025, amid market caution, analyst downgrades, and concerns over its proposed $9 billion acquisition of Core Scientific (CORZ).
Despite the pullback, CoreWeave trades at a relatively high forward sales multiple of 19.6x, supported by a substantial $25.9 billion revenue backlog from Q1, indicating strong confidence in long-term demand for its GPU-centric cloud platform.
Metric | Q2 FY2025 Estimate | Q1 FY2025 Actual | Change (QoQ) |
Total Revenue | $1.08B | $981.6M | +10% |
EPS | ($0.20) | ($1.49) | +86% |
Adjusted Operating Income | $140M–$170M | $162.6M | -14% to +5% |
Adjusted Operating Margin | 13–15% | 17% | -2pp to -4pp |
Source: CoreWeave, Yahoo Finance, GuruFocus, TradingKey
AI Infrastructure Demand and Client Diversification: CoreWeave’s growth is fueled by its GPU-intensive cloud platform, serving major clients including OpenAI (backed by an $11.9 billion contract), Microsoft (72% of Q1 2025 revenue), Meta Platforms, and IBM. Updates on client diversification efforts to reduce concentration risk, as well as adoption of CoreWeave’s AI Object Storage (CAIOS) and NVIDIA AI Enterprise software, will be key. Broader enterprise uptake or new long-term contracts would support sustained revenue growth.
Core Scientific Acquisition Progress: Announced July 7, 2025, CoreWeave’s $9 billion all-stock acquisition of Core Scientific adds approximately 1.3 gigawatts of power capacity, significantly expanding CoreWeave’s infrastructure footprint. This deal is expected to generate up to $10 billion in cumulative lease cost savings by 2027, improving CoreWeave’s long-term cost structure. However, the integration of Core Scientific’s lower-margin colocation business is projected to compress CoreWeave’s operating margins. Progress on integration timelines, realization of synergies, and margin management will be critical to CoreWeave’s near-term financial performance and execution of its growth strategy.
CapEx and Financial Sustainability: CoreWeave plans an aggressive $20–23 billion capital expenditure for 2025 to expand its data center capacity and support AI workload demand. This is partly funded by a $2.6 billion debt facility and $1.75 billion in senior notes. The company’s current ratio stands at 0.39, indicating tight liquidity. Management projects breakeven by 2026. Monitoring cash burn, vendor terms, and interest expense remains critical to assessing CoreWeave’s balance between growth investment and financial sustainability.
Strategic Acquisitions and Partnerships: Beyond the $9 billion Core Scientific deal, CoreWeave’s acquisition of Weights & Biases and a $4 billion post-Q1 contract with OpenAI highlight aggressive AI ecosystem expansion.
Regulatory and Trade Considerations: CFO Nitin Agrawal has indicated that proposed tariffs by President Trump are unlikely to materially affect operations due to CoreWeave’s reliance on domestic data centers. However, global trade uncertainties could impact GPU supply chains, notably with Nvidia as a key supplier. Supply chain resilience and diversification efforts are important to watch.
Industry Trends: The AI infrastructure market is projected to grow at 30%+ CAGR, driven by GPU-accelerated computing demand. CoreWeave’s vertically integrated model, owning power, data centers, and GPU fleets, positions it to capture significant share though competition from AWS, Google Cloud, and Microsoft Azure is intense. Key differentiators will include proprietary software like Fleet Lifecycle Controller and Tensorizer.
CoreWeave’s Q2 FY2025 earnings will be a key moment to gauge growth sustainability amid AI infrastructure demand. The outlook hinges on client diversification, Core Scientific integration progress, and capital expenditure management. Revenue beyond expecations and signs of broader enterprise adoption could drive upside, while margin pressure and customer concentration remain risks. The sizable revenue backlog and strong market positioning support long-term potential, but near-term volatility calls for caution.